Heat Biologics (HTBX) Says on Track to Report HS-410 and HS-110 Phase 1b, Phase 2 Data This Quarter
Tweet Send to a Friend
Heat Biologics, Inc. (Nasdaq: HTBX) announced that it continues to remain on track to report topline data this quarter from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
